Posts With Tag NASDAQ CNTA

Explore Centessa Pharmaceuticals PLC's latest 8-K report, revealing crucial stock details and financial data. Essential for investors and analysts in the biotech sector.

Dive into Centessa Pharmaceuticals' Amendment No. 1 on Form 10-Q/A, detailing executive trading arrangements, compliance updates, and insights for investors.

Explore Centessa Pharmaceuticals PLC's latest 8-K SEC filing, detailing stock information, financial insights, and key updates as of December 30, 2024. Ticker: CNTA.